• SA5 Systematic Literature Review of Unmet Needs and Burden of Disease in Generalized Anxiety Disorder (GAD)

    Jul 1, 2025, 00:00

  • EE329 Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024

    Jul 1, 2025, 00:00

  • HTA6 Real-World Evidence (RWE) in Health Technology Assessment (HTA): Global Guidelines on the Use of RWE in Evidence Generation for HTA Evaluation

    Jul 1, 2025, 00:00

  • EE449 Cost-Effectiveness of Pembrolizumab as Treatment forFIGO 2014Stage III-IVA Cervical Cancer in the United States

    Jul 1, 2025, 00:00

  • EE261 Cost-Effectiveness of Tumor-Treating Fields in Combination With Temozolomide for Glioblastoma Patients: An Italian Healthcare System Perspective

    Jul 1, 2025, 00:00

  • PCR196 Hypophosphatasia (HPP) Patient Treatment Experien A Mixed Methods Study Concept

    Jul 1, 2025, 00:00

  • PCR195 Treatment Preferences in Adults with Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines: Insights from CHOICE-CSU 2 Study

    Jul 1, 2025, 00:00

  • EE378 Healthcare Resource Utilization and Associated Costs in Patients With Transthyretin Cardiac Amyloidosis and Non-amyloid Heart Failure

    Jul 1, 2025, 00:00

  • EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States

    Jul 1, 2025, 00:00

  • RWD116 Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction

    Jul 1, 2025, 00:00

  • EE520 Evaluating the Budgetary Impact of the Wearable Cardioverter Defibrillator Service for Patients at Risk of Sudden Cardiac Death in the United Kingdom

    Jul 1, 2025, 00:00

  • RWD26 Market Size and Dispensing Patterns for Rheumatoid Arthritis Medications in SUS (Brazil, 2019–2023)

    Jul 1, 2025, 00:00

  • RWD94 Challenges in Projecting Treatment Journeys for ALK-mutated NSCLC: Addressing Uncertainty in PPS and Immature Overall Survival Data

    Jul 1, 2025, 00:00

  • EE384 Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study

    Jul 1, 2025, 00:00

  • P64 Impact of JCA and Project Orbis on the European Revenue Potential of an Oncology Product

    Jul 1, 2025, 00:00

  • EE491 Automating Health Economic Model Quality Check With a Model Generator

    Jul 1, 2025, 00:00

  • HSD76 A Real-World Study on Healthcare Resource Utilisation and Patient Care for People With Transthyretin Amyloid Polyneuropathy

    Jul 1, 2025, 00:00

  • EPH39 Estimating the Prevalence of Chronic Conditions in Population Health Management

    Jul 1, 2025, 00:00

  • CO74 Survival Outcomes of Stage IV Endometrial Cancer Patients with Lung Metastasis: A SEER-Based Cohort Study

    Jul 1, 2025, 00:00

  • RWD73 Use of Sensitivity Analysis to Address Potential Missing Data and Selection Bias from Linked Genomics Datasets in a Real-World Study of Patients Receiving Immune-Checkpoint Inhibitors for Metastatic Melanoma

    Jul 1, 2025, 00:00

  • PCR49 Exploring the Link Between Self-Efficacy and Medication Adheren Psychometric Evaluation of the Traditional Chinese Beliefs About Medicines Questionnaire-Specific in Adults With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • PCR2 Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America

    Jul 1, 2025, 00:00

  • EPH161 A German Claims Database Analysis of Epidemiology, Treatment Patterns, and Healthcare Resource Utilization of Patients with Primary Biliary Cholangitis (PBC)

    Jul 1, 2025, 00:00

  • CO12 Long-term Health Outcomes in Patients With Moderate-to-Severe Ulcerative Colitis Treated With Guselkumab: a Model-based Projection

    Jul 1, 2025, 00:00

  • MSR149 An AI-Powered RAG Based Framework for Data Extractions in Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • RWD143 Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data

    Jul 1, 2025, 00:00

  • MT13 Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective

    Jul 1, 2025, 00:00

  • PCR254 Symptom Burden of Acute Influenza Infection Among US Adults: An Interim Analysis of a Nationwide Prospective Study

    Jul 1, 2025, 00:00

  • EE439 Double Immune Checkpoint Inhibition as First-Line Treatment for BRAF-Mutant Advanced Melanoma: A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective

    Jul 1, 2025, 00:00

  • PCR83 Treatment Preferences Related to Long-Acting Injectable Buprenorphine Among Patients With Opioid Use Disorder in Australia, Finland, Germany, and Italy

    Jul 1, 2025, 00:00

  • HPR160 Relationships Between ICER Clinical Evidence Ratings and FDA Approval Decisions

    Jul 1, 2025, 00:00

  • HSD13 Exploring Oral Skeletal Muscle Relaxant Therapy in Adult Poststroke Patients in the US

    Jul 1, 2025, 00:00

  • EE269 Health Economic Assessment of High-Protein Diet Using High-Protein ONS for Weight Maintenance Following Weight Loss Using GLP-1RAs

    Jul 1, 2025, 00:00

  • MSR156 Examining Factors Contributing to Age of Late-Onset Autoimmune Disease in U.S. Adults Using Hierarchical Clustering Mechanisms

    Jul 1, 2025, 00:00

  • CO60 Relationship between Genetic Polymorphisms and Clinical Parameters in Mexican Postmenopausal Women: A Study on Cardiovascular Health

    Jul 1, 2025, 00:00

  • MSR127 The Role of Absolute Summaries in Detecting Intransitivity and Model Mis-Specification in Indirect Treatment Comparisons

    Jul 1, 2025, 00:00

  • EE212 Healthcare Resource Utilization Associated With Myotonic Dystrophy Type 1 With Complex Care Needs: Results From the Real-World IMPaCT Study

    Jul 1, 2025, 00:00

  • EE304 A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective

    Jul 1, 2025, 00:00

  • First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • PT21 US Commercial Health Plan Coverage of Oncology Therapies: 2017 - 2024

    Jul 1, 2025, 00:00

  • RWD168 Burden of Illness in CIDP: Results of a Multinational Real-World Survey

    Jul 1, 2025, 00:00

  • RWD30 Assessing and Comparing Inpatient Hospitalization Outcomes for COPD in the United States and OECD Countries

    Jul 1, 2025, 00:00

  • EE203 Comparing Ex-Vivo and In-Vivo Administration in CRISPR-Based Gene Therapies for Beta-Thalassemia: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • RWD112 Real-World Utilization of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults

    Jul 1, 2025, 00:00

  • EPH100 Acute eGFR Dip with SGLT2 Inhibitors vs. Other Antihyperglycemic Medications Among People with HIV

    Jul 1, 2025, 00:00

  • RWD135 Retrospective Databases in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research

    Jul 1, 2025, 00:00

  • SA12 Incidence, Prevalence, and Risk Factors of Giant Cell Arteritis: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE313 Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China

    Jul 1, 2025, 00:00

  • EE486 PICC Line (PICC) or Central Inserted Venous Catheter (CICC ) in Cancer Patients: Comparative Effectiveness and Cost-Effectiveness Analysis in Brasil/LATAM/LMIC

    Jul 1, 2025, 00:00

  • HSD15 Hypertrophic Scar Severity and Clinical Management in the Real-World Dermatology Setting

    Jul 1, 2025, 00:00

  • MSR101 Evaluating Pain Scores and Detecting NSCLC Using Named Entity Recognition and Agentic AI in Clinical Texts

    Jul 1, 2025, 00:00

  • PCR142 Utility Over Multiple Health Indexes in Non-Small Cell Lung Cancer: Survey Estimates for Patient-Centered Generalized Risk-Adjusted Cost-Effectiveness (GRACE)

    Jul 1, 2025, 00:00

  • HPR108 Trends in the Prescribing and Dispensing of GLP-1 Anti-Obesity Medications Among U.S. Adults with Cardiovascular Disease and Overweight or Obesity, 2021-2024

    Jul 1, 2025, 00:00

  • EE345 Assessing Health-Related Quality of Life Using the EQ-5D-5L Among Hong Kong Adult Population: The Role of Lifestyle Behaviours

    Jul 1, 2025, 00:00

  • HTA3 The Institute for Clinical and Economic Review and Joint Clinical Assessment: Insights for Manufacturers in an Evolving Health Technology Assessment Landscape

    Jul 1, 2025, 00:00

  • CO15 Exploring the Relationship Between Hemoglobin Levels and Clinical Outcomes in Anemic Dialysis-Dependent Chronic Kidney Disease Patients

    Jul 1, 2025, 00:00

  • EPH67 Association between Polypharmacy and Cognitive Limitations among Adults with Depression in the United States

    Jul 1, 2025, 00:00

  • HSD64 Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice

    Jul 1, 2025, 00:00

  • PCR155 Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States

    Jul 1, 2025, 00:00

  • HPR13 Are Commercial Insurance Premiums Associated With the 340B Drug Pricing Program?

    Jul 1, 2025, 00:00

  • Economic Evaluation Results Are Substantially Affected by Parameter Input Correlation

    Jul 1, 2025, 00:00

  • PCR28 Analysis of the Quality of Life of Patients Undergoing Hip Replacement Surgery Using the SF-36 Questionnaire

    Jul 1, 2025, 00:00

  • MSR1 Predictive Modeling for Designing a Personalized Statin Therapy: Optimizing Treatment Efficacy in Cardiovascular Disease Prevention

    Jul 1, 2025, 00:00

  • RWD3 The Relationship Between Weight and Disease Severity in Dogs with Chronic Kidney Disease: Results from a Real-World Study

    Jul 1, 2025, 00:00

  • PCR121 Elephant in the Room: Gap Between the Awareness and Need for Psycho-Social Support for Czech Lymphoma Patients as Captured Through the Analyzes of Social and Traditional Media

    Jul 1, 2025, 00:00

  • HPR122 Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts

    Jul 1, 2025, 00:00

  • PCR135 Disparities in COVID-19 Vaccination Uptake by Social Vulnerability Index: A US nationwide study

    Jul 1, 2025, 00:00

  • PT39 Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada

    Jul 1, 2025, 00:00

  • PCR225 Psychometric Validation and Meaningful Within-Patient Change of the FAACT-5IASS in Patients With Cancer Cachexia

    Jul 1, 2025, 00:00

  • MSR60 From AI to Experts: Understanding Pre-Election Inflation Narratives on Social Media via Sentiment and Topic Analysis

    Jul 1, 2025, 00:00

  • PCR165 Qualitative Interviews to Characterize Disease and Treatment Burden at Baseline in Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for the Treatment of Glycogen Storage Disease Type Ia

    Jul 1, 2025, 00:00

  • HPR156 The Inflation Reduction Act: Evaluating Impact on Medicare Drug Pricing, Innovation, and Access to Therapies

    Jul 1, 2025, 00:00

  • MSR49 The Quantification of Efficacy and Accuracy for Screening and Data Extraction in Perinatal Mood and Anxiety Disorders Studies: A Comparative Analysis of Traditional vs. GenAI-Powered Approaches

    Jul 1, 2025, 00:00

  • MSR76 A Flexible Dynamic Transmission Model Framework for Evaluating Tuberculosis Treatments: Methodological Challenges and Applications

    Jul 1, 2025, 00:00

  • CO36 Impact of Procedure Wait Times on One-Year Health Outcomes in Patients With Degenerative Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

    Jul 1, 2025, 00:00

  • PCR67 Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling

    Jul 1, 2025, 00:00

  • P21 Evaluating the Performance of Claude 3.5 Sonnet in Data Extraction Automation for Systematic Literature Reviews (SLRs)

    Jul 1, 2025, 00:00

  • EE390 Real-World Healthcare Resource Utilization (HCRU) and Economic Burden Among Patients With High-Risk Carcinoma-In-Situ (CIS) Non-Muscle Invasive Bladder Cancer (NMIBC) Using a Large Medicare Dataset

    Jul 1, 2025, 00:00

  • PT6 Comparison of Meaningful Score Difference Estimates From Longitudinal Item Response Theory and Anchor-Based Methods

    Jul 1, 2025, 00:00

  • MSR27 Barriers to CAR-T Therapy Access in the U.S.: A County-Level Analysis of Proximity and Sociodemographic Factors

    Jul 1, 2025, 00:00

  • HPR95 Participation in a Patient Support Program is Associated With Improved Access to Efgartigimod Treatment for Generalized Myasthenia Gravis in Patients Facing Social Determinants of Health (SDOH) Challenges

    Jul 1, 2025, 00:00

  • EE334 Economic Evaluation of Transient Elastography for Significant Fibrosis Detection in Patients With Diabetes Mellitus in Thailand

    Jul 1, 2025, 00:00

  • RWD63 Real-World Patient Persistence and Adheren A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population

    Jul 1, 2025, 00:00

  • HTA75 The Effectiveness of an Individualized eHealth Application on Glycemic Control in Diabetes Patients: A Randomized Controlled Trial

    Jul 1, 2025, 00:00

  • MSR113 Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population

    Jul 1, 2025, 00:00

  • RWD129 type 2 Inflammation and Exacerbator Profiles in COPD Patients: Real-World Data From a Brazilian Specialized Center

    Jul 1, 2025, 00:00

  • HPR159 Problems in the Drug System Related to Household Medicine Classification Criteria: A Gap Analysis for Modernizing the Criteria

    Jul 1, 2025, 00:00

  • RWD47 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia

    Jul 1, 2025, 00:00

  • PCR72 Optimizing Communication Strategies for COPD Management: Effectiveness of Educational Video and Pamphlet Interventions

    Jul 1, 2025, 00:00

  • EE293 A Comparative Assessment of ICER-Sponsored Versus Pharma-Sponsored Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • EE342 Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study

    Jul 1, 2025, 00:00

  • EE466 Budget Impact Analysis of the Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for disease prevention among Colombian Infants

    Jul 1, 2025, 00:00

  • EE213 Cost-Utility analysis of Dinutuximab Beta in Treating High-Risk Neuroblastoma: A Partitioned Survival Model Using R programming Language

    Jul 1, 2025, 00:00

  • MSR130 Using Real-World Data and Machine Learning to Identify Patients at Highest Risk for Hospitalization Following Respiratory Syncytial Virus Infection

    Jul 1, 2025, 00:00

  • PCR175 Are Cancer Trials Aligned With FDA's 2021 Guidance on Patient-Reported Outcomes?

    Jul 1, 2025, 00:00

  • OP10 The Impact of Research Sessions on Pharmacy Students’ Perceived Understanding in Research Design and Methodology

    Jul 1, 2025, 00:00

  • MSR120 Estimating Sample Size for Training Ensemble Machine Learning Models

    Jul 1, 2025, 00:00

  • PCR207 The Effect of Public Health Awareness Campaigns on Prostate Cancer-Related Online Information-Seeking Behavior: A Hungarian Experience

    Jul 1, 2025, 00:00

  • RWD43 Public Awareness and Perspectives on Respiratory Syncytial Virus Vaccination in Hong Kong: A Comprehensive Population-Based Study

    Jul 1, 2025, 00:00

  • HPR79 Unlocking AI's Potential in Pricing and Reimbursement: Insights Across Global Healthcare Archetypes

    Jul 1, 2025, 00:00

  • RWD108 A1c Improvement After Initiating Real-Time Continuous Glucose Monitoring Among People with Type 2 Diabetes Not on Insulin Therapy

    Jul 1, 2025, 00:00

  • EE253 Evaluation of Real-World Total Healthcare Costs Difference Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Breast Cancer Patients

    Jul 1, 2025, 00:00

  • HPR7 Software as a Medical Devi Current Regulations in North America and Europe

    Jul 1, 2025, 00:00

  • EPH106 Trend of Cervical Cancer Mortality in Colombia From 1998 to 2022

    Jul 1, 2025, 00:00

  • MT4 Exploring Mobile and Wearable Technology for Early Depression Detection and Monitoring

    Jul 1, 2025, 00:00

  • HSD61 Impact of Using Telehealth in Primary Care on Healthcare Resource Utilization, Costs, and Medication Adherence in Diabetic Patients

    Jul 1, 2025, 00:00

  • HPR167 Understanding How Formulary Pricing Models Shape Medication Accessibility and Financial Burden for Aging Populations

    Jul 1, 2025, 00:00

  • HPR29 Evaluating Therapeutic Alternative Selection in Medicare's Initial Drug Price Negotiation Explanations

    Jul 1, 2025, 00:00

  • RWD160 Optimizing Adherence to Intravenous Iron: A Geographic Analysis of Variability Within the United States

    Jul 1, 2025, 00:00

  • MSR30 Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis

    Jul 1, 2025, 00:00

  • HPR151 Comparing the Differences in MentalHealthcare Coverage Between US Public and Private Healthcare Insurers

    Jul 1, 2025, 00:00

  • PT30 Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023

    Jul 1, 2025, 00:00

  • PCR74 Utility of Mobile Health Applications, Wearable Devices, and Patient Generated Health Data in Menopause Research

    Jul 1, 2025, 00:00

  • PCR12 Hemolytic Disease of the Fetus and Newborn (HDFN): A Mixed-Methods Preference Study

    Jul 1, 2025, 00:00

  • PCR113 One Size Doesn’t Fit All: Learnings from a Pilot Survey Assessing Preferences for Improvement vs Worsening of Healthcare Professionals

    Jul 1, 2025, 00:00

  • MSR63 Extraction of Pulmonary Function Test Results from Unstructured Clinical Notes using a Retrieval-Augmented Generation Approach on a Major Cloud Platform

    Jul 1, 2025, 00:00

  • P45 Is There Any difference in Preferences Between Patients and Physicians? Evidence From Anti-Hyperglycemic Medications Choices for Type 2 Diabetes

    Jul 1, 2025, 00:00

  • HSD48 Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example

    Jul 1, 2025, 00:00

  • EE401 Return on Investment and Waste Considerations for the Implementation of Rechargeable Batteries in Video Laryngoscopes

    Jul 1, 2025, 00:00

  • EPH120 Clinical Characteristics and Healthcare Resource Utilization Among Patients Initiating Semaglutide 2.4mg Versus Those Not Treated With Anti-Obesity Medications

    Jul 1, 2025, 00:00

  • HSD66 Environmental Impact of Digital Remote Care Versus Standard Care for CML Patients

    Jul 1, 2025, 00:00

  • HSD35 Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • HTA43 Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)

    Jul 1, 2025, 00:00

  • MSR145 Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?

    Jul 1, 2025, 00:00

  • HPR4 Evolving HTA and Potential EU HTAR Ripple Effects in the US: Insights From a Stakeholder Survey

    Jul 1, 2025, 00:00

  • PCR95 State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials

    Jul 1, 2025, 00:00

  • MSR86 Machine Learning for Predictive Modeling of Hospitalization Risk in Myasthenia Gravis Patients Using the MGFA Global Patient Registry: Addressing Imbalanced Data in Real-World Evidence Scenarios

    Jul 1, 2025, 00:00

  • HTA66 Cost-Effectiveness of Intravenous Ferric Carboxy Maltose Versus Iron Sucrose to Treat Anemia in Pregnancy in Indian Context

    Jul 1, 2025, 00:00

  • EE377 What is the Role of Humans in a World of Artificial Intelligen An Exploratory Economic Evaluation of Human-AI Collaboration in Diabetic Retinopathy Screening

    Jul 1, 2025, 00:00

  • RWD141 Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes

    Jul 1, 2025, 00:00

  • EE397 Cost-Effectiveness of a Potential Policy to Ban Alcohol Advertising in Australia: A Modeling Study

    Jul 1, 2025, 00:00

  • MSR83 Early Detection of CHAPLE Disease in Pediatric Protein-Losing Enteropathy: A Feasibility Study

    Jul 1, 2025, 00:00

  • RWD105 Benchmarking Disease Prevalence in a Large Scale Electronic Health Record Data Network: An Assessment of Chronic and Rare Disease in the United States in 2023

    Jul 1, 2025, 00:00

  • HSD77 Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer

    Jul 1, 2025, 00:00

  • P59 Application of Bayesian Meta-Analysis in Synthesizing Health State Utility Values for QALY Estimation in Health Economic Evaluations: A Case Study on Advanced Neuroendocrine Tumors

    Jul 1, 2025, 00:00

  • PCR206 Incorporating Best-Worst Scaling into Attribute Selection for Stated Preference Research: A Study Based on Preference for Choosing Antidepressants

    Jul 1, 2025, 00:00

  • RWD155 Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States

    Jul 1, 2025, 00:00

  • HSD17 Co-Design of a Discrete Choice Experiment for Revascularization Decisions in Complex Coronary Heart Disease: Importance of Patient Perspectives

    Jul 1, 2025, 00:00

  • HPR71 Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies

    Jul 1, 2025, 00:00

  • HSD18 Variation in Recombinant Zoster Vaccine Uptake and Completion by Utilization of Office-Based Vaccination

    Jul 1, 2025, 00:00

  • HSD105 Development and Validation of a Machine Learning-Based Prediction Model for 30-Day COPD Readmissions: Enhancing Early Risk Stratification and Intervention

    Jul 1, 2025, 00:00

  • RWD68 AUVI-Q vs. Other Epinephrine Auto-Injector Prescription Was Associated With Reduced Inpatient Hospitalizations for Anaphylaxis in a US Retrospective Commercial Claims Analysis

    Jul 1, 2025, 00:00

  • MSR71 Joint Modeling for Clinical Interpretation of ctDNA Tumor Methylation Dynamics During Longitudinal Monitoring

    Jul 1, 2025, 00:00

  • EE274 Epidemiological Analysis and Patient Profile of Lung Cancer in the Brazilian Public Health System: A Real-World Data Study

    Jul 1, 2025, 00:00

  • EE301 Cost-effectiveness Analysis of Zavegepant in Acute Migraine Treatment

    Jul 1, 2025, 00:00

  • Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • P29 Real-World Treatment Patterns of Advanced Melanoma in the United States

    Jul 1, 2025, 00:00

  • EPH58 Evaluating the Cost-Effectiveness of Wastewater-Based Disease Surveillance

    Jul 1, 2025, 00:00

  • HSD63 Perspectives on Real-World Management of Stomatitis/Oral Mucositis (S/OM) From Oncologists With Experience Treating Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • HPR136 From Data to Decisions: The Role of Real-World Evidence in Recent Multiple Myeloma Drug Approvals in the US and EU

    Jul 1, 2025, 00:00

  • RWD72 Utilizing NLP to Enhance EHR Data Abstraction Accuracy in Waldenström Macroglobulinemia

    Jul 1, 2025, 00:00

  • PCR68 Perceived Health Status among Patients with Norovirus and Acute Gastroenteritis

    Jul 1, 2025, 00:00

  • RWD121 Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study

    Jul 1, 2025, 00:00

  • MSR67 Prognostic Model for Overall Survival in Colorectal Cancer Patients in the US: A Real World Data Study

    Jul 1, 2025, 00:00

  • CO28 Understanding Racial Differences in Emergency Room Visits for Patients with Lupus

    Jul 1, 2025, 00:00

  • CO92 Understanding Predictors of Early-Onset Colorectal Cancer in Personal Health Data with Machine Learning

    Jul 1, 2025, 00:00

  • CO89 Persistence of Infliximab Biosimilar versus Originator in Patients with Crohn's Disease: a Retrospective Cohort Study in China

    Jul 1, 2025, 00:00

  • EE249 Quantifying the Financial Burden of HbA1c Levels: A Retrospective Single-Center Analysis of Healthcare Costs in South Korean Diabetes Patients

    Jul 1, 2025, 00:00

  • PCR102 Information-Seeking Behavior of Over-the-Counter Medication From 2012 to 2022 Based Google Trends Data in Hungary

    Jul 1, 2025, 00:00

  • EE395 The Annual Economic Burden of RSV in High-Risk US Adults Aged 18-59: A Modeling Study

    Jul 1, 2025, 00:00

  • MSR70 Using Machine Learning to Estimate Perceptions and Future Prescribing Intentions of Health Care Providers: A Novel Application of Integrated Primary and Secondary Data in Understanding HCP Decision-Making

    Jul 1, 2025, 00:00

  • EE266 Exploring the Broader Societal Value of Pembrolizumab in Triple-Negative Breast Cancer and Cervical Cancer in Brazil

    Jul 1, 2025, 00:00

  • HSD4 Aggressive End-of-Life Care among Non-Small Cell Lung Cancer Medicare Patients

    Jul 1, 2025, 00:00

  • PCR168 Assessing the Validity of the SF-36 Health Survey Among Chinese Individuals with Spinal Cord Injuries

    Jul 1, 2025, 00:00

  • PT7 Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival

    Jul 1, 2025, 00:00

  • MSR8 Is Bayesian Statistics an Emerging Way for Extrapolating Survival in Cost-Effectiveness Analysis: A Systematic Review

    Jul 1, 2025, 00:00

  • EPH112 Frequency of Gram-Negative Bacteria at the Military Medical Center in Guatemala

    Jul 1, 2025, 00:00

  • EE221 How to Mitigate "Carer QALY Trap” when Including Caregiver QOL in Cost-Effectiveness Analysis: A Model Simulation Using Lecanemab in Japanese Patients with Alzheimer's Disease

    Jul 1, 2025, 00:00

  • EPH4 All for One and One for All? Patterns of Familial Influenza Vaccination

    Jul 1, 2025, 00:00

  • EE417 Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemoth ...

    Jul 1, 2025, 00:00

  • HSD83 Identifying Drivers for the Timely Referral of Patients for a Rare Disease Diagnosis: A Cross-Sectional Survey of Physicians in the United States

    Jul 1, 2025, 00:00

  • HSD97 Market Access as Defined by Professionals with Market Access Backgrounds - Scoping Review

    Jul 1, 2025, 00:00

  • HSD30 Characterization of Patients With Desmoid Tumors (DT) and Their Treatment Patterns Within an Academic Health System in the United States

    Jul 1, 2025, 00:00

  • PCR257 Real-World Evidence on Health-Related Quality of Life in Older Women With Advanced Breast Cancer Treated With CDK 4/6 Inhibitors

    Jul 1, 2025, 00:00

  • HTA49 Practical Application of the ICER-developed Clinical Trial Diversity Rating Tool

    Jul 1, 2025, 00:00

  • MSR150 Validity and Accuracy of Asthma-Related ICD-10 Diagnosis Codes in United States Real-World Administrative Database

    Jul 1, 2025, 00:00

  • HPR165 Application of England's Severity Weighting to Cost-Effectiveness Evaluations in Japan

    Jul 1, 2025, 00:00

  • MSR32 Dual Inhibitor Identification for Mutated IDH1/2 To Reduce D-2-Hydroxyglutarate in Glioblastoma

    Jul 1, 2025, 00:00

  • HPR164 Pediatric Opioid Prescribing Patterns: Analyzing Trajectories Using Texas PDMP Data in the Context of AAP Guidelines

    Jul 1, 2025, 00:00

  • PCR96 Sociodemographic Variations in Perceived Social Support Among Adults with Depression in the United States: Results From the National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • EPH63 Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study

    Jul 1, 2025, 00:00

  • EE418 Cost-effectiveness of Esketamine versus Real-world Treatments for Patients with Treatment-resistant Depression: A Multi-armed Modelling Study

    Jul 1, 2025, 00:00

  • EPH50 Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances

    Jul 1, 2025, 00:00

  • MT31 Adoption of a Drug Adherence-Enhancing Application To Achieve Optimal Medication Adherence and Blood Pressure Control Among Hypertensive Patients: A Randomized Controlled Trial

    Jul 1, 2025, 00:00

  • Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy

    Jul 1, 2025, 00:00

  • PCR158 Enhancing Patient Engagement in Pharmacist-Provided Medication Therapy Management for Chronic Conditions

    Jul 1, 2025, 00:00

  • EE527 Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments

    Jul 1, 2025, 00:00

  • HPR78 Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis

    Jul 1, 2025, 00:00

  • HTA54 Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan

    Jul 1, 2025, 00:00

  • EPH180 Trends of Mortality by Ulcer Decubitus in Colombia, 1998 - 2022

    Jul 1, 2025, 00:00

  • HPR123 Socioeconomic Vulnerabilities and Postpartum Depression: Assessingthe Aftermath of Dobbs v. Jackson in Trigger and Non-Trigger States

    Jul 1, 2025, 00:00

  • HPR18 Real-world Impact of the United States Preventive Services Task Force (USPSTF) Guidelines on HIV-1 Pre-Exposure Prophylaxis (PrEP) Ancillary Service Cost Sharing: Segmented Change Pre- and Post-Milestone USPSTF Timepoints

    Jul 1, 2025, 00:00

  • EPH132 Administrative Frequency of Alopecia Areata and Clinical Characteristics in a Colombian HMO: a Real-World Data Characterization For 2015-2023

    Jul 1, 2025, 00:00

  • EE379 Economic and Environmental Impact of Decentralized Cancer Care (DCC) in Oncology: An Innovative Experience in the French Alps

    Jul 1, 2025, 00:00

  • RWD87 How Well Does Hospital Billing Data Estimate Readmissions and Revision Risks After Spinal Fusion Surgery, Compared to Hospital Billing Linked to Claims Data?

    Jul 1, 2025, 00:00

  • PCR120 Experiences of Hungarian Mothers About Breastfeeding Support From Health Visitors

    Jul 1, 2025, 00:00

  • MT42 Bench Study Assessing the Impact of the Next Generation of Vitreoretinal-Cataract System on System Set-Up and Tear-Down Time for Vitreoretinal Surgery

    Jul 1, 2025, 00:00

  • RWD146 The Cost Burden of Infertility Therapy for Women with a History of Hysteroscopic Adhesiolysis Compared to Those with Other or no Previous Intrauterine Surgery

    Jul 1, 2025, 00:00

  • PCR208 Hematologist-Oncologist Preferences for Treating Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) using Tyrosine Kinase Inhibitors in Combination with Chemotherapy: A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • RWD33 Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017-2023)

    Jul 1, 2025, 00:00

  • P40 Cost-Effectiveness Analysis of Second-Generation Antipsychotic Long-Acting Injectables in Patients with Schizophrenia in the United States

    Jul 1, 2025, 00:00

  • EE457 Real-World Study Evaluating Drug Tolerability and Health Care Resource Use (HCRU) With Acalabrutinib vs. Ibrutinib in Treatment-Naïve Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

    Jul 1, 2025, 00:00

  • MT20 A Bibliometric Analysis to Estimate the Reach and Impact of the Peterson Health Technology Institute's Digital Health Value Assessments

    Jul 1, 2025, 00:00

  • CO4 Systematic Evaluation of Bone Health Dynamics Associated With GLP-1 Receptor Agonists in Type 2 Diabetes Patients: Fracture Risk and Osteoporotic Complications

    Jul 1, 2025, 00:00

  • MSR47 Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective

    Jul 1, 2025, 00:00

  • MT5 Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval

    Jul 1, 2025, 00:00

  • HTA20 Drivers of High ICERs in SMC Appraisals

    Jul 1, 2025, 00:00

  • R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior Code

    Jul 1, 2025, 00:00

  • HPR128 Cost of Vaccine Misinformation on the US Healthcare System

    Jul 1, 2025, 00:00

  • CO2 Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities

    Jul 1, 2025, 00:00

  • EE452 Evaluating the Cost-Benefit of Automated Dispensing Cabinets in Long-Term Care and Closed-Door Pharmacies

    Jul 1, 2025, 00:00

  • HSD95 Development of a Tool for Population Health Risk Stratification in Primary Care Through Consensus-Seeking Techniques

    Jul 1, 2025, 00:00

  • OP4 Perception Gap Between Preceptors and Pharmacy Students on Clinical Pharmacy Practice Education (CPPE) in Hospital Pharmacy

    Jul 1, 2025, 00:00

  • MT30 Clinical and Economic Outcomes of Ultrasonic Energy Devices Used in Patients Treated With Sleeve Gastrectomy

    Jul 1, 2025, 00:00

  • HTA53 The Dynamic Nature of Network Meta-Analysis: How Data Updates Could Influence Health Technology Assessment

    Jul 1, 2025, 00:00

  • PCR161 Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR255 Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value

    Jul 1, 2025, 00:00

  • EE205 Impact of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments: Brazilian Model

    Jul 1, 2025, 00:00

  • EE276 Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR229 Increasing Clinical Trial Participation in Native Hawaiian, Pacific Islander, and Asian Communities

    Jul 1, 2025, 00:00

  • RWD118 Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)

    Jul 1, 2025, 00:00

  • MSR13 TransportHealth: A Novel, Flexible, Open-Source R Package for Transportability and Generalizability Analysis

    Jul 1, 2025, 00:00

  • PCR122 A Critical Review of Existing Shared Decision-Making Measuring Approaches in Studies Using the Medical Expenditure Panel Survey (MEPS)

    Jul 1, 2025, 00:00

  • EE226 Household Costs and Other Societal Impacts for Individuals With Duchenne Muscular Dystrophy Stratified by Upper Limb Impairment: Results From a Caregiver Survey

    Jul 1, 2025, 00:00

  • EE238 Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data

    Jul 1, 2025, 00:00

  • EE375 Real-World Adherence, Healthcare Resource Utilization, And Costs Among Patients With Schizophrenia Utilizing Once-Monthly, Once-Every-Three-Months, And Once-Every-Six-Months Paliperidone Palmitate in the United States

    Jul 1, 2025, 00:00

  • HSD96 Conceptualisation and the Role of Market Access in Pharmaceutical Industry: A Qualitative Study

    Jul 1, 2025, 00:00

  • EE336 A Conceptual Epidemiological and Economic Model to Predict Obesity in Low- and Middle-Income Countries: A Meta-Synthesis

    Jul 1, 2025, 00:00

  • PCR204 Over 30 Years of Discrete Choice Experiment Studies in Health Economics: Systematic Review of Current Practice and Reflections on Evolving Practice

    Jul 1, 2025, 00:00

  • HPR141 Analysis of Patient Pathway on In Vitro Fertilization Treatment in Hungary

    Jul 1, 2025, 00:00

  • MSR81 Imputing Breast Cancer Stage in a Large EHR Dataset: Light Gradient Boosting Machine Algorithm and Explainable Artificial Intelligence

    Jul 1, 2025, 00:00

  • HTA5 Health Technology Assessment Evidence Requirements for Companion Diagnostics Associated with Targeted Therapies in Oncology

    Jul 1, 2025, 00:00

  • EE407 The Cost-effectiveness Analysis of Gene Therapy for Severe Hemophilia B Patients in China: A Microsimulation Experiment Study

    Jul 1, 2025, 00:00

  • RWD113 Impact of NGS Testing Timing on Real-World Treatment Patterns and Clinical Outcomes in Colorectal Cancer: A Retrospective Observational Study

    Jul 1, 2025, 00:00

  • EPH181 Recent Evidence on the Comprehensive Burden of Pediatric Invasive Meningococcal Disease in the United States: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • CO30 The Relationship Between Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma: A Meta-Regression of Clinical Trial Data

    Jul 1, 2025, 00:00

  • P15 Boosting Predictive Power: Thoughtfully Unleashing the Potential of Machine Learning In Real-World Healthcare Outcome Estimation

    Jul 1, 2025, 00:00

  • MT25 Modeling Challenges and Critiques in Economic Evaluations of Medical Devices: A Review of NICE Medical Technologies Guidance

    Jul 1, 2025, 00:00

  • PCR110 Exploring Treatment Preferences for Rare Diseases: A Systematic Review of Quantitative Preference Studies

    Jul 1, 2025, 00:00

  • OP2 A Descriptive Analysis of Key Findings From the 2024-2025 ISPOR Student Interest Survey

    Jul 1, 2025, 00:00

  • CO73 Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (7.5mg) across 1.5 Years

    Jul 1, 2025, 00:00

  • EPH66 Antidiabetic Medication Uses Among Pregnant Women: Real-World Prescription Pattern in South Korea

    Jul 1, 2025, 00:00

  • HSD8 A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England

    Jul 1, 2025, 00:00

  • HSD28 Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)

    Jul 1, 2025, 00:00

  • HSD52 Understanding Barriers to the Early Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease from the Perspective of Physicians and Patients: Results from a Real-World Survey in Germany

    Jul 1, 2025, 00:00

  • HSD32 Innovative Strategy for Resistant Depression and Suicidal Ideation: HEOR Analysis From the Perspective of BRAZIL / LATAM / LMIC

    Jul 1, 2025, 00:00

  • MSR110 From Manual to Machine: A Deep Dive into AI-Powered Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • MSR84 Data Extraction in Literature Reviews Using an Artificial Intelligence Model: Prompt Development and Testing

    Jul 1, 2025, 00:00

  • HSD27 Choosing Wisely?' Use of Staging Imaging in US Veteran Patients With Prostate Cancer

    Jul 1, 2025, 00:00

  • EPH179 Associations Between Post-Diagnostic Statin Use, Cholesterol Levels, and Mortality Risk Among American Breast Cancer Patients: Insights from the National Health and Nutrition (NHANES) Survey

    Jul 1, 2025, 00:00

  • EPH125 Validation of ICD Code-Based Identification of Myocarditis Among mRNA COVID Vaccine Immunized Patients and COVID-Infected Patients

    Jul 1, 2025, 00:00

  • MSR91 Reliability of Insurance Claims to Categorize Obesity in Patients with Obstructive Sleep Apnea

    Jul 1, 2025, 00:00

  • EE369 Healthcare Resource Utilization (HCRU), Costs, and Outcomes Among Patients With Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) in the United States: A Retrospective, Real-World Analysis of Administrative Claims Data

    Jul 1, 2025, 00:00

  • P51 How Can We Make Innovative Payment and Pricing Schemes Work? Findings of the European Union Research Project HI-PRIX

    Jul 1, 2025, 00:00

  • P47 Patient Preferences on Understanding Medical Tests and Monitoring Equipment in Hospitalized Care

    Jul 1, 2025, 00:00

  • PCR162 Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil

    Jul 1, 2025, 00:00

  • EPH71 Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)

    Jul 1, 2025, 00:00

  • HSD3 Gaps In Screening Among Medicare Patients With A Ruptured Abdominal Aortic Aneurysm

    Jul 1, 2025, 00:00

  • HSD73 Real-World Primary Care Data on Menopause: Insights into Diagnoses, Treatment Patterns, and Care Gaps

    Jul 1, 2025, 00:00

  • HPR38 Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)

    Jul 1, 2025, 00:00

  • PCR55 Parental Self-Efficacy in the Management of Pediatric Type 1 Diabetes Mellitus: A Subgroup Analysis Among CGM Sensor Users

    Jul 1, 2025, 00:00

  • HSD21 A Qualitative Assessment of Emergency Physician Perceptions and Experiences with Acute Pain Management

    Jul 1, 2025, 00:00

  • HSD38 Insights into Ophthalmology Workforce Dynamics and Procedural Trends: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • P17 Health Inequality Aversion in the United States and Americans' Views on Health Inequality

    Jul 1, 2025, 00:00

  • HPR133 Coverage Gaps: Do U.S. Commercial Health Plans Have Concordant Alzheimer's Disease Therapy Testing Policies?

    Jul 1, 2025, 00:00

  • PCR249 Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada

    Jul 1, 2025, 00:00

  • EE496 Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management

    Jul 1, 2025, 00:00

  • HTA67 Developing a Selection Framework for Comparator in HTA-Based Inclusion in China's National Reimbursement Drug List

    Jul 1, 2025, 00:00

  • RWD83 Variation in Provider Reimbursement for Biosimilars and Reference Biologics by Commercial Health Plans

    Jul 1, 2025, 00:00

  • EPH98 Prevalence of Diabetes and Its Impact on Hospitalization among Patients with Cancer: A Population-Based Study in the U.S

    Jul 1, 2025, 00:00

  • PCR75 Adverse Events: Does Experience Impact Preferences? A Review of the Literature

    Jul 1, 2025, 00:00

  • PT8 Time-Driven Activity-Based Costing in Healthcare: Should We Adjust for Inflation or Reapply the Method?

    Jul 1, 2025, 00:00

  • EE386 Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada

    Jul 1, 2025, 00:00

  • HPR58 Exploring Contemporary Variability in PDMP Budgets and Data Sharing Across the United States

    Jul 1, 2025, 00:00

  • PT41 Structured Evaluation of Oncology Real-World Data Quality for Practical Applications

    Jul 1, 2025, 00:00

  • PT20 Estimating the Cost at which GLP-1 RAs Would become Cost-Effective for Multimorbid Type 2 Diabetes Patients in Canada

    Jul 1, 2025, 00:00

  • MSR147 Evaluating Imaging Artificial Intelligence (AI) Matching Real-World Digital Twins (rwDTs) Into an External Control Arm (ECA) for MYSTIC: A Phase 3 Clinical Trial in Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • HSD91 Development of an Online Patient Decision Aid and Culturally Conscious Toolkit for Inflammatory Bowel Disease

    Jul 1, 2025, 00:00

  • CO48 Analyzing the Association Between Statin Use and New Onset Diabetes in the US: A Retrospective Analysis Using Integrated EHR and Claims Data

    Jul 1, 2025, 00:00

  • PCR159 Measurement of Short-Term Functional Outcome Using Modified Rankin Scale in Patients With Acute Ischaemic Stroke

    Jul 1, 2025, 00:00

  • MSR122 MetaSLR: AI-Driven Screening and Extraction Platform with Integrated Quality Assurance Checkpoints

    Jul 1, 2025, 00:00

  • PCR41 Exploring the Landscape of Patient-Reported Outcomes in PCOS Clinical Trials

    Jul 1, 2025, 00:00

  • EE350 Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada

    Jul 1, 2025, 00:00

  • PT22 Payer Archetypes and Decision-Making in the United States (US): A framework for Generalised Cost-Effectiveness Analysis (GCEA) Value Elements to Optimize Patient Access and Equity

    Jul 1, 2025, 00:00

  • RWD12 Patient-Reported Symptoms and Quality of Life: A Real-World Survey of Patients With Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • EPH41 Use of Artificial Intelligence for Rapid Epidemiology Reviews With Pooled Prevalence and Incidence Estimates

    Jul 1, 2025, 00:00

  • HSD47 Increase in Healthcare Professionals' Willingness to Counsel HPV Vaccine Hesitant Parents Post-Pandemic: Results from a National Survey

    Jul 1, 2025, 00:00

  • P61 Implementation of the IRA: Evolving Perspectives from US Stakeholders

    Jul 1, 2025, 00:00

  • PCR233 Physician, Patient and Caregiver Concordance in a Real-World US Generalized Myasthenia Gravis Population

    Jul 1, 2025, 00:00

  • MSR157 Analytical Approaches to Estimate Medication Persistence From Electronic Health Record Data: A Study of Tyrosine Kinase Inhibitors in Patients With Epidermal Growth Factor Receptor-Positive Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • MT35 Race and Ethnicity Differences in the HPV Vaccine Initiation Prompted by Electronic Reminders

    Jul 1, 2025, 00:00

  • P28 The Use of Artificial Intelligence in the Development of Economic Models

    Jul 1, 2025, 00:00

  • HPR106 Regional Differences in IVF Utilization Rates in Hungary in the Last Decade

    Jul 1, 2025, 00:00

  • HPR88 Factors Affecting Per Capita Costs in Subdistrict Health Promotion Hospitals (SHPH) After Transfer to Provincial Administrative Organizations (PAO): A Study of Allocation Models in Thailand

    Jul 1, 2025, 00:00

  • CO53 Comorbidity Burden Among Patients with Bullous Pemphigoid in the US Medicare Population

    Jul 1, 2025, 00:00

  • PT38 Assessing the Impact of Digital Ecosystem Engagement on Outcomes in Sickle Cell Disease (SCD) Patients

    Jul 1, 2025, 00:00

  • SA10 Improving the Face Validity and Clinical Relevance of a Cancer Epidemiology Microsimulation Model Using a Novel Advisory Group Approach

    Jul 1, 2025, 00:00

  • HSD93 Real-World Peripheral Embolization Characteristics Among Medicare Patients

    Jul 1, 2025, 00:00

  • HPR16 Emerging Trends in List Price Adjustment Strategies Following Implementation of the Inflation Reduction Act

    Jul 1, 2025, 00:00

  • HSD58 Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease

    Jul 1, 2025, 00:00

  • MSR78 Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia

    Jul 1, 2025, 00:00

  • HTA16 AMCP Dossier v5.0: U.S. Payer Preferences and Utilization to Support Formulary Decision Making

    Jul 1, 2025, 00:00

  • EPH69 Racial and Ethnic Disparities in Healthcare Expenditures Among United States Older Adults with Joint Pain

    Jul 1, 2025, 00:00

  • P34 Are Pediatric Trials Including More Patient-Centered Outcomes?

    Jul 1, 2025, 00:00

  • MSR35 Training and Validation Methods of Artificial Intelligence Tools For Automated Systematic Reviews In Pharmacoepidemiology and Health Technology Assessment: A Systematic Review

    Jul 1, 2025, 00:00

  • PCR199 Measuring Patient Engagement: The Importance of a Framework

    Jul 1, 2025, 00:00

  • MT14 Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review

    Jul 1, 2025, 00:00

  • MSR139 Application of Generative Artificial Intelligence for Extracting Structured Data from Unstructured Bladder Cancer Pathology Reports

    Jul 1, 2025, 00:00

  • PCR126 Balancing Vulnerability and Freedom: Perspectives on HIV Cure-Related Trials With Analytical Treatment Interruption Among People With HIV and Healthcare Practitioners in the United States

    Jul 1, 2025, 00:00

  • CO86 Comparing Chemotherapy, Monotherapy, and Combination Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer Progression-Free Survival and Overall Survival: Systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EE473 Cost-Efficiency Modeling of Conversion to Biosimilar Rituximab-pvvr in Diffuse Large B-Cell Lymphoma in Medicare

    Jul 1, 2025, 00:00

  • CO72 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Experienced Patients with T2D

    Jul 1, 2025, 00:00

  • RWD85 Short- and Longer-Term Healthcare Resource Utilization and Related Costs of Stroke in the Brazilian Private Market from 2019 to 2023

    Jul 1, 2025, 00:00

  • MSR98 AI-Enhanced Literature Review: Comparing Advanced Pancreatic Cancer Trial Outcomes According to Performance Status

    Jul 1, 2025, 00:00

  • EE399 Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • EE501 Cost-Effectiveness Analysis of Screening for Cervical Lesion and Diagnosis and Treatment of Cervical Cancer In Nigeria

    Jul 1, 2025, 00:00

  • RWD50 Real-World Healthcare Resource Utilization and Related Costs Associated with Ovarian Cancer in the Brazilian Private Market

    Jul 1, 2025, 00:00

  • EE358 Validation of a Flexible Partitioned Survival and 3-State Markov Model for Cost-Effectiveness Analyses in Oncology

    Jul 1, 2025, 00:00

  • EE460 Impact of Newborn Screening for Duchenne Muscular Dystrophy: A Model-Based Analysis

    Jul 1, 2025, 00:00

  • MSR66 Developing a Risk Prediction Model for the Identification of Necrotizing Fasciitis (NF) in Patients

    Jul 1, 2025, 00:00

  • HPR74 Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade

    Jul 1, 2025, 00:00

  • CO82 Comparative Effectiveness and Safety of Factor Xa Inhibitors in Atrial Fibrillation: A Systematic Literature Review of Real-World Evidence in Europe

    Jul 1, 2025, 00:00

  • EPH44 Changes in Outpatient Visits in a Medicaid Population in the Face of Physician Shortages

    Jul 1, 2025, 00:00

  • RWD77 Patterns in Provider Specialties and Adoption of Non-Invasive Tests (NITs) for Diagnosing Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Jul 1, 2025, 00:00

  • HPR109 Impact of Increased Patients' Out-of-Pocket Costs on Oral Anticoagulant Discontinuation among Medicare Beneficiaries with Atrial Fibrillation Treated with Apixaban

    Jul 1, 2025, 00:00

  • HTA57 Impact of China's NRDL Value-Rating System on Reimbursement and Pricing of Innovative Therapies

    Jul 1, 2025, 00:00

  • EPH18 Estimating Lung Cancer Screening Utilization in the US Using the 2023 Behavioral Risk Factor Surveillance System Data

    Jul 1, 2025, 00:00

  • RWD23 Unlocking the Potential of Radiology Reports Using NLP: A Real-World Data Approach to Rotator Cuff Tear Severity

    Jul 1, 2025, 00:00

  • EE306 Healthcare Resource Utilization of Tafamidis Patients in the United States

    Jul 1, 2025, 00:00

  • HTA51 Broadening the Scope of Value: Evaluating Payer Perspectives and Insights on ICER's Latest Initiatives and Tools

    Jul 1, 2025, 00:00

  • MSR54 Leveraging Artificial Intelligence for Thematic Analysis of Qualitative Transcripts: A Feasibility Study in Insurance Payer Interviews

    Jul 1, 2025, 00:00

  • CO20 Real-World Overall Survival of Multiple Myeloma Patients in a Colombian HMO During 2015-2023

    Jul 1, 2025, 00:00

  • EE402 Cost-Effectiveness Analysis of Eladocagene Exuparvovec-tneq for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) and Comparison with Other Rare Disease One-Time Treatments in the United States

    Jul 1, 2025, 00:00

  • EPH160 Prevalence of Mental Health Conditions Among Individuals With Sickle Cell Disease in Texas Medicaid

    Jul 1, 2025, 00:00

  • PCR178 Qualitative Insights on Meaningful Change in Symptoms and Impacts for Patients With Alpha-1 Antitrypsin Deficiency

    Jul 1, 2025, 00:00

  • EE505 Economic Evaluation of Next-Generation Sequencing Technologies in Paediatric Patient Groups With Rare Diseases: a Systematic Review

    Jul 1, 2025, 00:00

  • PCR157 Estimated Impact of Pre-Exposure Prophylaxis for COVID-19 on Quality of Life and Physical Distancing Among Immunocompromised Individuals and Caregivers

    Jul 1, 2025, 00:00

  • EE325 A Systematic Literature Review of the Economic Burden in Patients with Ehlers-Danlos Syndrome in the United States

    Jul 1, 2025, 00:00

  • PT36 Psychometric Evidence Supporting the Use of the EQ-5D in Long COVID: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR2 Mapping Disparities in Clinical Trial Enrollment Among HCC Patients: Insights From Social Determinants of Health

    Jul 1, 2025, 00:00

  • EE300 Ferric Derisomaltose for the Treatment of Iron Deficiency Anemia: A Real-World Evidence Study

    Jul 1, 2025, 00:00

  • PCR103 Attitude, Knowledge, and Intention to Receive Shingles Vaccine Using the Theory of Planned Behavior in Saudi Arabia

    Jul 1, 2025, 00:00

  • EPH34 Systematic Literature Review on the Economic Burden of Myopia

    Jul 1, 2025, 00:00

  • EE497 Cost-Effectiveness of Robot-Assisted and Laparoscopic Radical Nephrectomy Versus Open Radical Nephrectomy in the Treatment of Renal Cell Carcinoma

    Jul 1, 2025, 00:00

  • EE521 Generalized Cost-Effectiveness Analysis with Dynamic Prevalence for Improving Health Equity Among Rare Diseases

    Jul 1, 2025, 00:00

  • EPH192 The Trajectory of Ground Glass Nodule Patients in China: A Real-World Perspective

    Jul 1, 2025, 00:00

  • PT4 A Systematic Review on Economic Evaluations of Comparisons Between CAR-T Therapies in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Jul 1, 2025, 00:00

  • EE282 Quality-Adjusted Life Year (QALY) Results From a Cost-Effectiveness Model for Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Relapsed/Refractory Multiple Myeloma (RRMM)

    Jul 1, 2025, 00:00

  • PCR197 Impact of Cirrhosis on Health-Related Quality of Life and Activity Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada

    Jul 1, 2025, 00:00

  • MSR6 Staffing Resource Use: A Cost Impact Model for the Utilization and Implementation of Medications for Opioid Use Disorder Within US Jails And Prisons

    Jul 1, 2025, 00:00

  • PCR86 Health utilities of patients with multidrug-resistant tuberculosis and its influencing factors: A cross-sectional study based on EQ-5D-5L in China

    Jul 1, 2025, 00:00

  • EE514 Disease Burden Estimates in Economic Evaluation Studies of Respiratory Syncytial Virus (RSV) Maternal Immunization: A Systematic Review

    Jul 1, 2025, 00:00

  • HTA17 Are There Intersections in Evidence Requirements for Health Technology Assessment Agencies across North America, Europe and the Asia-Pacific?

    Jul 1, 2025, 00:00

  • RWD147 The Role of Social Determinants of Health (SDoH) Data in Improving Risk Predictions

    Jul 1, 2025, 00:00

  • MSR152 A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review

    Jul 1, 2025, 00:00

  • MT1 Value of Personalized Refractive Procedure: A Survey of Perceived Clinical Outcomes, Practice Benefits, and Patient Satisfaction in China

    Jul 1, 2025, 00:00

  • MT34 Effectiveness of Digital Care Platforms for Cancer Patients: A Systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • CO52 Glucocorticoid Exposure and the Risk of Serious Infections in CIDP

    Jul 1, 2025, 00:00

  • MSR103 Regularized MAIC As a Modern Solution for Indirect Treatment Comparison Challenges

    Jul 1, 2025, 00:00

  • RWD67 Analysis of Disease Progression in 769 Patients With Dominant Alport Syndrome

    Jul 1, 2025, 00:00

  • EPH92 Transfusion Needs For Patients With Myelofibrosis In Latin America

    Jul 1, 2025, 00:00

  • MSR52 Tailoring Generalized Cost-Effectiveness Analysis (GCEA) to the U.S. Setting: the Importance of Using the Right Prices

    Jul 1, 2025, 00:00

  • EE446 The Blinded Economic Impact of Chemotherapy: How Adverse Effects Affect Costs During Bladder Oncology Treatments

    Jul 1, 2025, 00:00

  • CO9 Exploring Patient Perspectives of Statistically Derived Item Weights for Composite Scores in Spinocerebellar Ataxia

    Jul 1, 2025, 00:00

  • EE279 Economic Burden of Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP): A Large United States (US) Nationwide Claims Analysis

    Jul 1, 2025, 00:00

  • CO13 Dupilumab Improves Health-Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: Results From the BOREAS and NOTUS Trials

    Jul 1, 2025, 00:00

  • HPR87 Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies

    Jul 1, 2025, 00:00

  • PCR51 Information-Seeking Behavior of the Hungarian Population Regarding Lung Cancer: A Digital Epidemiological Study Using Google Trends™

    Jul 1, 2025, 00:00

  • PT42 Designing Value-Based Dental Insuran A Multicriteria Decision Analysis

    Jul 1, 2025, 00:00

  • HSD14 Colorectal Cancer Screening Initiation Modalities Among Newly Age-Eligible Medicaid-Insured Individuals in Texas

    Jul 1, 2025, 00:00

  • EE512 How HTA Should Consider the Global Value of Health Products to Support Public Decision?

    Jul 1, 2025, 00:00

  • MSR111 Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HTA85 Developing a Value Assessment Framework for Modified New Drugs In China

    Jul 1, 2025, 00:00

  • HPR60 What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus

    Jul 1, 2025, 00:00

  • EE207 Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease

    Jul 1, 2025, 00:00

  • PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

    Jul 1, 2025, 00:00

  • EPH151 Depression Literacy in the Middle East and North Africa: A Scoping Review

    Jul 1, 2025, 00:00

  • MSR134 A Web-Based Application To Automate the Development of State-Transition Models in Oncology Using Published Survival Curves and Bayesian Calibration

    Jul 1, 2025, 00:00

  • PCR182 Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients With C1 Inhibitor Deficiency (Type I/II) and =8 Attacks Per Month

    Jul 1, 2025, 00:00

  • MSR85 Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders

    Jul 1, 2025, 00:00

  • EE493 Cost Effectiveness of Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in China

    Jul 1, 2025, 00:00

  • RWD59 Uptake of national guidance for prescribing of SGLT-2 inhibitors for type 2 diabetes in the UK

    Jul 1, 2025, 00:00

  • EE450 National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States

    Jul 1, 2025, 00:00

  • EPH168 Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses

    Jul 1, 2025, 00:00

  • P60 Feasibility of Replicating a Published Health Economic Model From an ICER Report Using Generative AI

    Jul 1, 2025, 00:00

  • MSR59 An Open-Source R-Shiny Application Designed to Perform Frequentist and Bayesian Mixed Model Repeated Measures (MMRM)

    Jul 1, 2025, 00:00

  • HSD89 Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR16 Integrating Patient-Reported Outcomes in Clinical Care: Opportunities and Roadblocks from the Clinician Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • RWD145 Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States

    Jul 1, 2025, 00:00

  • RWD159 Burden of Illness in US Patients With Liver Cancer and Kidney Disease: A Real-World Claims Analysis

    Jul 1, 2025, 00:00

  • EE295 Modeling the Potential Health Benefits of Improving Nutrition in Australian Indigenous Populations

    Jul 1, 2025, 00:00

  • CO61 Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis

    Jul 1, 2025, 00:00

  • RWD124 Healthcare Resource Utilization for Medicare Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and Exacerbations Coinfected with Pseudomonas aeruginosa

    Jul 1, 2025, 00:00

  • EE315 Real-World Disease Management Costs for U.S. Patients With Muscle Invasive Bladder Cancer (MIBC) Following Radical Cystectomy (RC) in Contemporary Practice

    Jul 1, 2025, 00:00

  • MT11 How Does it Stack Up? User Comparison of the Ambu aScope 5 Uretero Against Reusable Ureteroscope Platforms

    Jul 1, 2025, 00:00

  • PCR200 Exploring the Impact of Exercise Variability of Mental Health: Results From the 2024 US National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • EE411 Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder

    Jul 1, 2025, 00:00

  • MSR37 Improve Analyst Accuracy in Systematic Literature Reviews Using Reliant Tabular and LLM-Based Relevance Scoring

    Jul 1, 2025, 00:00

  • MT9 Assessment of Artificial Intelligence-Enabled Health Technologies: Our Initial Experience at Canada's Drug Agency

    Jul 1, 2025, 00:00

  • HPR6 Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years

    Jul 1, 2025, 00:00
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »